被标记为β-内酰胺类抗生素过敏与全膝关节置换术后五年内假体周围感染相关
该纵向研究分析1993年1月至2021年12月间4730例全膝关节置换术(TKA)患者,发现被标记为β-内酰胺类(BL)抗生素过敏者术后五年内假体周围感染(PJI)发生率高于无标记者(3.0% vs 0.7%),BL过敏标记为PJI独立危险因素(HR 4.86)。经药物激发试验,95%受检标记患者成功去除过敏标记,作者建议优先对BL过敏标记患者进行正式过敏评估。
要点
- 被标记为BL过敏的TKA患者术后五年内PJI发生率3.0%(5/165),无标记者为0.7%(34/4,565),差异有统计学意义(p=0.001)。
- BL过敏标记是PJI的独立危险因素,HR 4.86(95%CI 2.05至11.53),p<0.001。
- 经药物激发试验阴性后,95%(21/22)受评估的BL过敏标记患者成功去除标记。
核心结论
- 被标记为BL过敏的TKA患者与术后PJI风险增加相关,尤其在前五年内。
- 鉴于误标率高,作者建议应优先对被标记为BL过敏的患者进行正式过敏评估。
- 作者鼓励进一步研究术前抗生素过敏去除标记措施的影响。
研究设计与样本
- 纵向研究,分析1993年1月至2021年12月间所有接受TKA的患者数据。
- 共纳入4,730例TKA,比较有和无BL过敏标记患者的PJI结局。
- 对BL过敏标记且已行或计划行TKA的患者进行前瞻性正式过敏评估。
主要发现
- 4,730例TKA中PJI总体发生率为1.0%(47/4,730)。
- BL过敏标记组术后五年内PJI发生率为3.0%(5/165),无标记组为0.7%(34/4,565),p=0.001。
- BL过敏标记为PJI独立危险因素,HR 4.86(95%CI 2.05至11.53),p<0.001。
- 药物激发试验阴性后,95%(21/22)受评估的BL过敏标记患者成功去除标记。
关键数值与推荐
- BL过敏标记组术后五年内PJI发生率3.0%(5/165),无标记组0.7%(34/4,565),p=0.001。
- BL过敏标记与PJI独立相关,HR 4.86(95%CI 2.05至11.53),p<0.001。
- 药物激发试验后95%(21/22)受评估患者成功去除BL过敏标记。
临床怎么用
- 作者建议应优先对被标记为BL过敏的患者进行正式过敏评估。
- 作者鼓励进一步研究术前抗生素过敏去除标记措施的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Periprosthetic joint infections (PJIs) represent a significant complication of total knee arthroplasty (TKAs). However, the influence of drug or beta-lactam (BL) antibiotic allergy labelling of patients on PJI remains largely unknown. In this study, we examine the association between patients labelled with a BL allergy and the occurrence of PJI among patients undergoing TKA. We also assess the prevalence of incorrect patient labelling and explore the feasibility of a multidisciplinary drug allergy testing initiative to detect mislabelling. METHODS: Longitudinal data from all patients who underwent TKA between January 1993 and December 2021 were analyzed. We investigated the association between different risk factors and PJI, with particular focus on patients labelled as having an antibiotic drug allergy. The outcomes of patients with and without a labelled BL allergy were compared. Additionally, patients labelled as having a BL allergy and who had undergone or were scheduled for TKA were prospectively investigated by formal allergy assessment. RESULTS: Out of 4,730 TKAs, the overall incidence of PJI was 1.0% (47/4,730). Patients labelled as having a BL allergy had a higher incidence of PJI within the first five years post-TKA compared to those without (3.0% (5/165) vs 0.7% (34/4,565); p = 0.001). The presence of a BL allergy label was identified as an independent risk factor for PJI (hazard ratio 4.86 (95% CI 2.05 to 11.53); p < 0.001). Following negative drug provocation testing, the majority of patients (95% (21/22)) evaluated with BL allergy labels were successfully delabelled. CONCLUSION: In this longitudinal study, patients labelled as having a BL allergy were associated with having increased risk of PJI following TKA, particularly within the first five years. Given the high rate of patients being mislabelled, we recommend that patients labelled as having a BL allergy should be prioritized for formal allergy assessment and evaluation. Further studies on the impact of preoperative antibiotic allergy delabelling initiatives should be encouraged.
引用
- Chiang V, Mak HWF, Cheung A, et al. Labelling patients as allergic to beta-lactam antibiotics is associated with periprosthetic joint infection up to five years following knee arthroplasty. Bone Joint J. 2025. PMID: 40306661. doi:10.1302/0301-620X.107B5.BJJ-2024-1007.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。